Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиCastle Biosciences Мультипликаторы 2011-2024 | CSTL
Мультипликаторы по годам Castle Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-11.4 | -9.8 | -34.4 | -123.0 | 48.9 | - | - | - | - | - | - | - | - |
P/S |
3.0 | 4.8 | 11.5 | 20.2 | 5.0 | - | - | - | - | - | - | - | - |
EPS |
-2.1 | -2.6 | -1.2 | -0.5 | 0.3 | -5.3 | - | - | - | - | - | - | - |
EV (Enterprise Value) |
619 млн | 586 млн | 799 млн | 879 млн | 194 млн | 28 млн | 24.1 млн | - | - | - | - | - | - |
EBITDA per Share |
-2.08 | -2.39 | -1.46 | -0.321 | 0.895 | - | - | - | - | - | - | - | - |
EV/EBITDA |
-21.2 | -141.8 | 24.0 | - | - | - | - | - | - | - | - | ||
PEG |
- | 0.28 | 0.31 | - | - | - | - | - | - | - | - | ||
P/B |
1.7 | 1.7 | 2.6 | 3.0 | 3.0 | - | - | - | - | - | - | - | - |
P/CF |
-116.6 | -15.9 | -56.8 | 247.4 | 42.4 | - | - | - | - | - | - | - | - |
ROE % |
-14.69 | -16.82 | -7.60 | -2.47 | 6.20 | - | - | - | - | - | - | - | - |
ROA % |
-12.68 | -15.01 | -6.76 | -2.34 | 4.41 | - | - | - | - | - | - | - | - |
ROCE % |
-17.37 | -18.25 | -9.73 | -1.56 | 7.02 | - | - | - | - | - | - | - | - |
Current Ratio |
7.3 | 9.3 | 9.1 | 20.6 | 7.6 | - | - | - | - | - | - | - | - |
DSO |
51.3 | 54.3 | 58.3 | 74.3 | 103.1 | - | - | - | - | - | - | - | - |
DIO |
48.4 | 34.2 | 48.9 | 83.6 | 61.8 | - | - | - | - | - | - | - | - |
DPO |
60.9 | 41.5 | 53.6 | 79.1 | 93.1 | - | - | - | - | - | - | - | - |
Операционный цикл |
99.7 | 88.5 | 107.2 | 157.9 | 164.9 | - | - | - | - | - | - | - | - |
Финансовый цикл |
38.8 | 47.0 | 53.6 | 78.8 | 71.7 | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Castle Biosciences
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.09 | - | -0.26 | -0.7 | -1.1 | - | -0.77 | -0.06 | -0.97 | - | -0.47 | -0.35 | -0.17 | -0.23 | -0.23 | -0.08 | 0.03 | 0.12 | 0.43 | -1.05 | -1.22 | 1.49 | -2.33 | -2.15 | -2.37 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.08 | - | -0.33 | -0.76 | -1.08 | - | -0.79 | -0.13 | -0.88 | - | -0.39 | -0.32 | -0.16 | - | -0.18 | -0.03 | 0.06 | - | 0.35 | 0.32 | -0.13 | - | -1.45 | -1.37 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-9.17 | -14.33 | -19.25 | -22.38 | -17.82 | -11.51 | -14.37 | -12.32 | -14.04 | -6.00 | -7.18 | -5.42 | -3.63 | -2.47 | 1.12 | 9.09 | 7.93 | 6.20 | -3.05 | -3.83 | 3.24 | 11.57 | 18.41 | 12.31 | 6.73 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-8.13 | -12.84 | -17.26 | -20.10 | -16.05 | -10.32 | -13.04 | -11.34 | -13.00 | -5.72 | -6.83 | -5.15 | -3.45 | -2.34 | 0.49 | 6.42 | 5.67 | 4.41 | 19.95 | -0.33 | -13.35 | -12.22 | -29.48 | -14.08 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-11.94 | -16.27 | -21.50 | -24.24 | -19.59 | -12.35 | -15.22 | -12.85 | -14.03 | -6.01 | -6.95 | -5.02 | -3.06 | -0.84 | 4.36 | 10.50 | 11.37 | 5.54 | 10.58 | 10.42 | 14.42 | 9.76 | 9.76 | 4.71 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
8.2 | 7.3 | 8.7 | 9.1 | 10.2 | 9.3 | 9.9 | 12.5 | 9.4 | 9.1 | 19.7 | 22.2 | 23.3 | 18.6 | 18.6 | 18.6 | 18.6 | 3.5 | 3.5 | 3.5 | 3.5 | 0.7 | 0.7 | 0.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
50.6 | - | 50.7 | 53.7 | 55.6 | - | 56.0 | 55.7 | 63.2 | - | 70.7 | 64.4 | 54.1 | 67.3 | 76.5 | 91.6 | 71.8 | 75.8 | 90.5 | 124.5 | 139.9 | 96.5 | 297.2 | 138.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
51.2 | - | 47.9 | 43.9 | 38.1 | - | 36.9 | 33.9 | 33.5 | - | 45.6 | 54.7 | 68.2 | - | 81.7 | 94.3 | 65.9 | - | 66.1 | 56.6 | 60.5 | - | 59.6 | 30.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
64.3 | - | 56.7 | 70.5 | 65.8 | - | 46.6 | 39.1 | 45.0 | - | 41.9 | 43.7 | 64.3 | - | 77.3 | 89.2 | 75.6 | - | 99.6 | 85.4 | 94.7 | - | 98.0 | 49.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
101.8 | - | 98.6 | 97.6 | 93.7 | - | 92.9 | 89.6 | 96.7 | - | 116.3 | 119.1 | 122.3 | 67.3 | 158.2 | 185.8 | 137.7 | 75.8 | 156.6 | 181.1 | 200.4 | 96.5 | 356.8 | 169.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
37.5 | - | 41.9 | 27.1 | 27.8 | - | 46.3 | 50.5 | 51.8 | - | 74.3 | 75.4 | 58.0 | 67.3 | 80.9 | 96.6 | 62.1 | 75.8 | 56.9 | 95.7 | 105.8 | 96.5 | 258.8 | 119.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD